Alyssa Oplt

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Shaina F Bruce, Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth C Stock, Alyssa Oplt, Barbara Blachut, Mary M Mullen, Lindsay M Kuroki, Andrea R Hagemann, Carolyn K McCourt, Premal H Thaker, Dineo Khabele, Matthew A Powell, David G Mutch, Leah P Shriver, Gary J Patti, Katherine C Fuh
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis. Molecular cancer therapeutics 21 (8) (2022)
Mary M Mullen, Elena Lomonosova, Michael D Toboni, Alyssa Oplt, Emily Cybulla, Barbara Blachut, Peinan Zhao, Hollie Noia, Daniel Wilke, Erinn B Rankin, Lindsay M Kuroki, Andrea R Hagemann, Ian S Hagemann, Carolyn K McCourt, Premal H Thaker, David G Mutch, Matthew A Powell, Nima Mosammaparast, Alessandro Vindigni, Katherine C Fuh
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress. Molecular cancer research : MCR (2021)

Alyssa Oplt.css-eqlu8i{font-size:small;padding-left:4px;}